Roughly one in five adults across the country will hit a wall with anxiety or depression this year. We know what works—the medicine is safe, the science is settled, and frankly, the clinical results are predictable once we find the right fit. For years, the real hurdle hasn't been the chemistry of the brain; it's been the logistical nightmare of finding a provider who actually has an opening. [1]
The Gold Standard: What the guidelines actually recommend
When we're dealing with moderate to severe symptoms, the industry data is clear: use an SSRI or SNRI alongside a solid therapist. While either can do the heavy lifting on its own, they're simply better as a team. Of course, I'm going to nag you about the basics too. If you aren't sleeping, getting some sunlight, or moving your body—or if you're leaning too hard on alcohol—even the best meds are going to struggle to get you where you want to go. [2]
Which SSRI should you start with?
Look—any clinician who tells you they know exactly which pill you'll respond to is guessing. Sertraline, escitalopram, and fluoxetine are the heavy hitters because they have the best stats, so we usually start there. My approach is to start small, stay patient for a 6–8 week trial at a real therapeutic dose, and then pivot quickly if your brain doesn't like the first option. [3]
What happens if the first round fails?
- First, we check the dose. Most 'failures' I see in clinic are just people who were under-dosed or quit after ten days.
- We can try a different drug in the same family, like moving from Zoloft to Lexapro.
- We might jump to an SNRI like Cymbalta or add Wellbutrin into the mix.
- If the foundation is good but not enough, we add a secondary booster medication.
- For the really stubborn cases that refuse to budge, we look at ketamine therapy.
The nuances of treating anxiety
Treating generalized anxiety or panic is its own animal. Paradoxically, SSRIs can make you feel more jittery for the first week or two before the calm sets in. This is why I start folks at half-doses and focus on grounding skills early on. We try to keep benzodiazepines as a 'break glass in case of emergency' tool—they're great for a crisis, but the dependency risk is too high for everyday use. [1]
The reality of online psychiatry
The core of mental health care is really just a conversation, a prescription, and checking back in to see how you feel. That's it. It turns out video calls and secure messaging are actually perfect for this. For most people with straightforward depression or anxiety, online care isn't just a convenience—it's more consistent. It eliminates the 'commute of shame' to a waiting room and makes it much easier to actually stick with your treatment plan.
Knowing when to go to the office
I'll be straight with you: online care has its limits. If you're in a crisis or thinking about self-harm, please stop reading this and call 911 immediately. Telehealth also isn't the right move if we're dealing with active psychosis, severe substance abuse, or eating disorders that need a hands-on medical team.
Available across Florida
Reset My Vitality is a Florida-licensed telehealth practice. The treatments covered in this guide are available to patients statewide, with medication shipped directly to your door. Explore the program for your city:
- Mental Health in Miami, FL
- Mental Health in Miami Beach, FL
- Mental Health in Fort Lauderdale, FL
- Mental Health in West Palm Beach, FL
- Mental Health in Boca Raton, FL
- Mental Health in Orlando, FL
- Mental Health in Tampa, FL
- Mental Health in Jacksonville, FL
- Mental Health in Naples, FL
Key Clinical Studies
A short, responsible summary of recent peer-reviewed research relevant to this topic. This is for education only, not medical advice.
American Journal of Psychiatry · 2006
Key finding: In the STAR*D trial, sequential, personalized antidepressant treatment achieved remission in roughly two-thirds of patients with major depression over up to four steps.
Why it matters: Supports an iterative, clinician-guided approach to medication management for anxiety and depression.
View studyComparative efficacy and acceptability of 21 antidepressant drugs
The Lancet · 2018
Key finding: A meta-analysis of 522 trials found that all 21 antidepressants studied were more effective than placebo for major depression in adults, with meaningful differences in efficacy and tolerability.
Why it matters: Reinforces that medication choice matters and benefits from individualized prescribing.
View studyKetamine vs ECT for non-psychotic treatment-resistant major depression
New England Journal of Medicine · 2023
Key finding: Intravenous ketamine was non-inferior to electroconvulsive therapy for non-psychotic treatment-resistant depression, with roughly 55% of ketamine patients showing sustained improvement.
Why it matters: Reinforces ketamine as a credible option for patients who have not responded to traditional antidepressants.
View studyScientific References
Peer-reviewed studies and reviews cited in this article.
- [1]Glue P, et al. Extended-release ketamine tablets for treatment-resistant depression. Nat Med. 2024. View study
- [2]Yavi M, et al. Ketamine treatment for depression: a review. 2022. View study
- [3]Tully JL, et al. Ketamine treatment for refractory anxiety: A systematic review. 2022. View study